Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

By Eerola H.  

Cancer Causes and Control, Vol. 12, Iss. 8, 2001-10 ,pp. : 739-746

Springer Publishing Company

Access to resources Recommend Favorite

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families

By Kang Peter  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 579-584

Springer Publishing Company

Access to resources Recommend Favorite

Clinical management of women with genomic BRCA1 and BRCA2 mutations*

By Chang J.   M. Elledge R.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 101-113

Springer Publishing Company

Access to resources Recommend Favorite

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

By Møller Pål   Stormorken Astrid   Holmen Marit   Hagen Anne   Vabø Anita   Mæhle Lovise  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 607-614

Springer Publishing Company

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite